These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16719822)

  • 21. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children.
    Grussendorf-Conen EI; Jacobs S
    Pediatr Dermatol; 2002; 19(3):263-6. PubMed ID: 12047649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical Imiquimod in the Treatment of Conjunctival Actinic Keratosis.
    Rowlands MA; Giacometti JN; Servat J; Materin MA; Levin F
    Ophthalmic Plast Reconstr Surg; 2017; 33(1):e21-e23. PubMed ID: 25853505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of human papilloma virus in a 6-month-old infant with imiquimod 5% cream.
    Schaen L; Mercurio MG
    Pediatr Dermatol; 2001; 18(5):450-2. PubMed ID: 11737697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
    Carrasco D; vander Straten M; Tyring SK
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imiquimod as an immune response modulator in infectious conditions.
    Skinner RB
    Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imiquimod.
    Garland SM
    Curr Opin Infect Dis; 2003 Apr; 16(2):85-9. PubMed ID: 12734440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imiquimod applied topically: a novel immune response modifier and new class of drug.
    Miller RL; Gerster JF; Owens ML; Slade HB; Tomai MA
    Int J Immunopharmacol; 1999 Jan; 21(1):1-14. PubMed ID: 10411278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe reaction to 5% imiquimod cream with excellent clinical and cosmetic outcomes.
    Greenberg HL; Cohen JL; Rosen T; Orengo I
    J Drugs Dermatol; 2007 Apr; 6(4):452-8. PubMed ID: 17668546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of the area of skin capable of being covered by the application of 250 mg of 5% imiquimod cream.
    Berman B; Ricotti CA; Cazzaniga A; Davis SC
    Dermatol Surg; 2004 May; 30(5):784-6. PubMed ID: 15099325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel dermatologic uses of the immune response modifier imiquimod 5% cream.
    Berman B; Poochareon VN; Villa AM
    Skin Therapy Lett; 2002 Nov; 7(9):1-6. PubMed ID: 12548325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of topical therapies in the management of cutaneous disease.
    Skinner R
    J Cutan Med Surg; 2004; 8 Suppl 3():22-31. PubMed ID: 15647859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report.
    Orengo I; Rosen T; Guill CK
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S225-8. PubMed ID: 12271283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of perianal warts in a child with 5% imiquimod cream.
    Gruber PC; Wilkinson J
    J Dermatolog Treat; 2001 Dec; 12(4):215-7. PubMed ID: 12241631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of action and other potential roles of an immune response modifier.
    Gaspari AA
    Cutis; 2007 Apr; 79(4 Suppl):36-45. PubMed ID: 17508494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology.
    Berman B
    Int J Dermatol; 2002 May; 41 Suppl 1():7-11. PubMed ID: 12087816
    [No Abstract]   [Full Text] [Related]  

  • 37. Imiquimod 5% cream for the treatment of actinic keratoses.
    Somani N; Rivers JK
    Skin Therapy Lett; 2005 Mar; 10(2):1-6. PubMed ID: 15986078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actinic keratosis treated with an immune response modifier: a case report of six patients.
    Bianchi L; Campione E; Marulli GC; Costanzo A; Chimenti S
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():39-41. PubMed ID: 14616813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream.
    Cowen E; Mercurio MG; Gaspari AA
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S240-8. PubMed ID: 12271286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imiquimod in clinical practice.
    Edwards L
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.